The Singlet Oxygen Strategy (SO2S) is a multi-partner network funded by a Marie Curie Initial Training Networks (ITN) under the European Union programme FP7-PEOPLE-2012-ITN.
The SOS network seeks to exploit Singlet Oxygen (1O2) as a green and benign oxidant for use in novel synthetic methodologies, crosslinking strategies, bioconjugation procedures and materials production. The chemistry described herein generates the means to both understand and influence biological systems by providing probes and reagents – from analytical methods to new drugs - and to modulate materials towards optimal properties.
This project was funded by the European Union’s Seventh Framework Programme (FP7/2007-2013)/Marie Curie ITN Grant Agreement No. 316975.What is a Marie Curie ITN?
Marie Curie Initial Training Networks (ITNs) offer early-stage researchers the opportunity to improve their research skills, join established research teams and enhance their career prospectsWhat is singlet oxygen?
In the most basic terms, singlet oxygen is a more reactive form of the oxygen that we breathe from the air around us. Singlet oxygen is used for a wide range of applications, including medical treatments and diagnosis, cleaning wastewater, and conducting and controlling oxidation reactions. Therefore, the work that we do in this ITN project is diverse and relevant.
No current news or blog articles